Has FDG PET/CT an impact on the management of patients with anal carcinoma?

被引：1

作者：

Vercellino, L. ^{[1
]}

de Parades, V. ^{[2
]}

Nataf, V. ^{[1
]}

Kerrou, K. ^{[1
]}

Huchet, V. ^{[1
]}

Bauer, P. ^{[2
]}

Pascal, O. ^{[1
]}

Touboul, E. ^{[3
]}

Montravers, F. ^{[1
]}

Talbot, J. -N. ^{[1
]}

机构：

[1] Univ Paris 06, Hop Tenon, Nucl Med Serv, F-75020 Paris 20, France

[2] Grp Hosp Diaconesses Croix St Simon, Serv Proctol Med Interventionnelle, F-75012 Paris, France

[3] Univ Paris 06, Hop Tenon, Serv Oncol Radiotherapie, F-75020 Paris 20, France

来源：

MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE | 2010年 / 34卷 / 02期

关键词：

Anal carcinoma; FDG; PET/CT; Impact on management; POSITRON-EMISSION-TOMOGRAPHY; EPIDERMOID CARCINOMA; CANCER; CT; F-18-FDG; SURVIVAL; TUMORS; HIV-1;

D O I：

10.1016/j.mednuc.2009.12.005

中图分类号：

R36 [病理学];

学科分类号：

100104 ;

摘要：

Purpose. To evaluate the impact of FDG PET/CT on the management of patients referred for the staging and/or the follow-up of anal carcinoma, and PET/CT on patient management. Patients and methods. We included patients referred to our department for anal carcinoma whose therapeutic management was evaluable thanks to follow-up data during at least 6 months. Results. Data of 44 patients were analysed: 22 had PET/CT for initial staging and 36 during follow-up. PET/CT had impact in nine patients out of 44 (20%) and it was relevant in eight of them. Conclusion. FDG PET/CT is an accurate imaging modality in anal cancer, its impact on patient management is more obvious when persistence or recurrence of disease is suspected. (C) 2009 Elsevier Masson SAS. Tous droits reserves.

引用

页码：96 / 102

页数：7

共 30 条

[21] Magnetic resonance imaging of anal cancer
Roach, SC
Hulse, PA
Moulding, FJ
Wilson, R
Carrington, BM
[J]. CLINICAL RADIOLOGY, 2005, 60 (10) : 1111 - 1119
[22] Management of anal canal cancer
Sato, H
Koh, PK
Bartolo, DCC
[J]. DISEASES OF THE COLON & RECTUM, 2005, 48 (06) : 1301 - 1315
[23] Whole-body positron emission tomography in patients with HIV-1 infection
Scharko, AM
Perlman, SB
Pyzalski, RW
Graziano, FM
Sosman, J
Pauza, CD
[J]. LANCET, 2003, 362 (9388) : 959 - 961
[24] CT OF MALIGNANT ANAL-CANAL TUMORS
SCHERRER, A
REBOUL, F
MARTIN, D
DUPUY, JC
MENU, Y
[J]. RADIOGRAPHICS, 1990, 10 (03) : 433 - 453
[25] Tumor response and survival predicted by post-therapy FDG-PET/CT in anal cancer
Schwarz, Julie K.
Siegel, Barry A.
Dehdashti, Farrokh
Myerson, Robert J.
Fleshman, James W.
Grigsby, Perry W.
[J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 71 (01): : 180 - 186
[26] Shankar LK, 2006, J NUCL MED, V47, P1059
[27] Positron emission tomography for pretreatment staging and posttreatment evaluation in cancer of the anal canal
Trautmann, TG
Zuger, JH
[J]. MOLECULAR IMAGING AND BIOLOGY, 2005, 7 (04) : 309 - 313
[28] van Waarde A, 2004, J NUCL MED, V45, P695
[29] Vatra B, 2002, GASTROEN CLIN BIOL, V26, P150
[30] Welton Mark Lane, 2004, Surg Oncol Clin N Am, V13, P263, DOI 10.1016/j.soc.2003.12.005

← 1 2 3 →